High Salt—High Reproducibility - Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System
Aplikace | 2020 | Agilent TechnologiesInstrumentace
HPLC
ZaměřeníFarmaceutická analýza
VýrobceAgilent Technologies
Klíčová slovadar, hic, brentuximab, vedotin, antibody, drug, subtraction, biocompatible, area, adc, salt, mau, molecules, precision, species, retention, attached, characterization, high, mab, hydrophobic, linked, protein, solvent, analysis, completely, sst, response, conjugated, shell, conjugates, feature, cysteine, baseline, drugs, iron, from, buffers, blank, min, drugconjugate, antibodies, time, free, ndrug, monoclonal, chromatogram, small, stainless, heptahydrate
Podobná PDF
Convenient and Reliable Analysis of Antibody Drug Conjugates
2021|Agilent Technologies|Aplikace
Application Note Biopharma/Pharma Convenient and Reliable Analysis of Antibody Drug Conjugates Drug-to-antibody determination with ternary gradients on the Agilent 1260 Infinity II Prime Bio LC ×101 1.20 D2 1.15 1.10 1.05 1.00 0.95 0.90 0.85 0.80 D4 0.75 Response (mAU)…
Klíčová slova
brentuximab, brentuximabvedotin, vedotinisopropanol, isopropanolhic, hicternary, ternarydar, darspecies, speciesantibody, antibodybio, bioorganic, organicdrug, drugbuffers, bufferssolvent, solventsalt, saltadcs
Analysis of Cysteine-Linked Antibody Drug Conjugates
2017|Agilent Technologies|Aplikace
Analysis of Cysteine-Linked Antibody Drug Conjugates Using Hydrophobic Interaction Chromatography on the Agilent 1260 Infinity II Bio-inert LC Application Note Biologics and Biosimilars Author Abstract Sonja Schneider Hydrophobic interaction chromatography (HIC) is frequently used for the Agilent Technologies, Inc. determination…
Klíčová slova
brentuximab, brentuximabvedotin, vedotindar, darhic, hicdrug, drugantibody, antibodyhydrophobic, hydrophobicmmae, mmaeadcs, adcsadc, adctige, tigeinteraction, interactionmab, mablinked, linkedcysteine
Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
2021|Agilent Technologies|Aplikace
Application Note Biopharma/Pharma Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS Authors David L. Wong and Sarah M. Stow Agilent Technologies, Inc. Abstract Antibody drug conjugates (ADCs), which comprise a monoclonal antibody (mAb) conjugated to a small molecule drug…
Klíčová slova
dimension, dimensiondar, daradcs, adcsadc, adcsecond, secondnative, nativehic, hicadvancebio, advancebiocounts, countsmab, mabdrug, drugdeconvoluted, deconvolutedfirst, firstconjugated, conjugatedintact
High-Performance Biopharma Analysis - Application compendium
2021|Agilent Technologies|Příručky
Agilent InfinityLab Bio LC Solutions High-Performance Biopharma Analysis Application compendium 2 Overcome Analytical Challenges in Biopharma The growing complexity of biopharma analysis calls for innovation that delivers excellence across the biopharmaceutical workflow. The Agilent InfinityLab Bio LC Solutions comprise a…
Klíčová slova
retention, retentionbio, biomin, mingradient, gradienttime, timenistmab, nistmabresponse, responsemau, maupeptide, peptidemapping, mappingagilent, agilentcharge, chargemab, mabrsd, rsdantibody
